Synthesis of thrombin-inhibiting heparin mimetics without side effects

Maurice Petitou, Jean-Pascal Hérault, André Bernat, Pierre-Alexandre Driguez, Philippe Duchaussoy, Jean-Claude Lormeau and Jean-Marc Herbert ()
Additional contact information
Maurice Petitou: Sanofi Recherche
Jean-Pascal Hérault: Sanofi Recherche
André Bernat: Sanofi Recherche
Pierre-Alexandre Driguez: Sanofi Recherche
Philippe Duchaussoy: Sanofi Recherche
Jean-Claude Lormeau: Sanofi Recherche
Jean-Marc Herbert: Sanofi Recherche

Nature, 1999, vol. 398, issue 6726, 417-422

Abstract: Abstract Unwanted side effects of pharmacologically active compounds can usually be eliminated by structural modifications. But the complex heterogeneous structure of the polysaccharide heparin1 has limited this approach to fragmentation, leading to slightly better-tolerated heparin preparations of low molecular mass2. Despite this improvement, heparin-induced thrombocytopaenia3 (HIT), related to an interaction with platelet factor 4 (PF4) and, to a lesser extent, haemorrhages4, remain significant side effects of heparinotherapy. Breakthroughs in oligosaccharide chemistry5 made possible the total synthesis of the pentasaccharide antithrombin-binding site of heparin6,7. This pentasaccharide represents a new family of potential antithrombotic drugs, devoid of thrombin inhibitory properties, and free of undesired interactions with blood and vessel components. To obtain more potent and well-tolerated antithrombotic drugs, we wished to synthesize heparin mimetics able to inhibit thrombin, that is, longer oligosaccharides. Like thrombin inhibition, undesired interactions are directly correlated to the charge and the size of the molecules8, so we had to design structures that were able to discriminate between thrombin and other proteins, particularly PF4. Here we describe the use of multistep converging synthesis to obtain sulphated oligosaccharides that meet these requirements.

Date: 1999
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/18877 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:398:y:1999:i:6726:d:10.1038_18877

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/18877

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().